Biologics Contract Development Market Size, Share, Growth, Trends, Company Analysis, Regional Insights and Forecast 2020 - 2027

Published Date : Nov 2020 | No. of Pages : 250 Pages | Category : Healthcare


Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Biologics Contract Development Market, By Source

7.1.  Biologics Contract Development Market, By Source Type, 2020-2030

7.1.1.    Microbial

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Mammalian

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Others

7.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Biologics Contract Development Market, By Product Service Type

8.1.  Biologics Contract Development Market, By Product Service Type, 2020-2030

8.1.1.    Cell Line Development

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Process Development

8.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Biologics Contract Development Market, By Disease Indication

9.1.  Biologics Contract Development Market, By Disease Indication, 2020-2030

9.1.1.    Oncology

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Immunological disorders

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Cardiovascular disorders

9.1.3.1.        Market Revenue and Forecast (2016-2030)

9.1.4.    Hematological disorders

9.1.4.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Biologics Contract Development Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, By Source (2016-2030)

10.1.2.  Market Revenue and Forecast, By Product Service Type (2016-2030)

10.1.3.  Market Revenue and Forecast, By Disease Indication (2016-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, By Source (2016-2030)

10.1.4.2.      Market Revenue and Forecast, By Product Service Type (2016-2030)

10.1.4.3.      Market Revenue and Forecast, By Disease Indication (2016-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, By Source (2016-2030)

10.1.5.2.      Market Revenue and Forecast, By Product Service Type (2016-2030)

10.1.5.3.      Market Revenue and Forecast, By Disease Indication (2016-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, By Source (2016-2030)

10.2.2.  Market Revenue and Forecast, By Product Service Type (2016-2030)

10.2.3.  Market Revenue and Forecast, By Disease Indication (2016-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, By Source (2016-2030)

10.2.4.2.      Market Revenue and Forecast, By Product Service Type (2016-2030)

10.2.4.3.      Market Revenue and Forecast, By Disease Indication (2016-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, By Source (2016-2030)

10.2.5.2.      Market Revenue and Forecast, By Product Service Type (2016-2030)

10.2.5.3.      Market Revenue and Forecast, By Disease Indication (2016-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, By Source (2016-2030)

10.2.6.2.      Market Revenue and Forecast, By Product Service Type (2016-2030)

10.2.6.3.      Market Revenue and Forecast, By Disease Indication (2016-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, By Source (2016-2030)

10.2.7.2.      Market Revenue and Forecast, By Product Service Type (2016-2030)

10.2.7.3.      Market Revenue and Forecast, By Disease Indication (2016-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, By Source (2016-2030)

10.3.2.  Market Revenue and Forecast, By Product Service Type (2016-2030)

10.3.3.  Market Revenue and Forecast, By Disease Indication (2016-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, By Source (2016-2030)

10.3.4.2.      Market Revenue and Forecast, By Product Service Type (2016-2030)

10.3.4.3.      Market Revenue and Forecast, By Disease Indication (2016-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, By Source (2016-2030)

10.3.5.2.      Market Revenue and Forecast, By Product Service Type (2016-2030)

10.3.5.3.      Market Revenue and Forecast, By Disease Indication (2016-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, By Source (2016-2030)

10.3.6.2.      Market Revenue and Forecast, By Product Service Type (2016-2030)

10.3.6.3.      Market Revenue and Forecast, By Disease Indication (2016-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, By Source (2016-2030)

10.3.7.2.      Market Revenue and Forecast, By Product Service Type (2016-2030)

10.3.7.3.      Market Revenue and Forecast, By Disease Indication (2016-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, By Source (2016-2030)

10.4.2.  Market Revenue and Forecast, By Product Service Type (2016-2030)

10.4.3.  Market Revenue and Forecast, By Disease Indication (2016-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, By Source (2016-2030)

10.4.4.2.      Market Revenue and Forecast, By Product Service Type (2016-2030)

10.4.4.3.      Market Revenue and Forecast, By Disease Indication (2016-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, By Source (2016-2030)

10.4.5.2.      Market Revenue and Forecast, By Product Service Type (2016-2030)

10.4.5.3.      Market Revenue and Forecast, By Disease Indication (2016-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, By Source (2016-2030)

10.4.6.2.      Market Revenue and Forecast, By Product Service Type (2016-2030)

10.4.6.3.      Market Revenue and Forecast, By Disease Indication (2016-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, By Source (2016-2030)

10.4.7.2.      Market Revenue and Forecast, By Product Service Type (2016-2030)

10.4.7.3.      Market Revenue and Forecast, By Disease Indication (2016-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, By Source (2016-2030)

10.5.2.  Market Revenue and Forecast, By Product Service Type (2016-2030)

10.5.3.  Market Revenue and Forecast, By Disease Indication (2016-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, By Source (2016-2030)

10.5.4.2.      Market Revenue and Forecast, By Product Service Type (2016-2030)

10.5.4.3.      Market Revenue and Forecast, By Disease Indication (2016-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, By Source (2016-2030)

10.5.5.2.      Market Revenue and Forecast, By Product Service Type (2016-2030)

10.5.5.3.      Market Revenue and Forecast, By Disease Indication (2016-2030)

Chapter 11.  Company Profiles

11.1.              WuXi Biologics

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Abzena Ltd.

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              Fujifilm Diosynth Biotechnologies

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              KBI Biopharma

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              AGC Biologics

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              SE Thermo Fisher (Patheon)

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              LakePharma

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              Genscript Biotech Corporation

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              Bionova Scientific

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

11.10.           Boehringer Ingelheim BioXcellence

11.10.1.               Company Overview

11.10.2.               Product Offerings

11.10.3.               Financial Performance

11.10.4.               Recent Initiatives

11.11.           STC Biologics, Inc.

11.11.1.               Company Overview

11.11.2.               Product Offerings

11.11.3.               Financial Performance

11.11.4.               Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

Glossary of Terms

Featured Research Reports

  • Featured Research Reports

    Audiology Devices Market (By Product: Hearing Aids, Cochlear Implants; By Technology: Digital, Analog; By Sales Channel: Retail, E-commerce) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.

    Read more...
  • Featured Research Reports

    Micro-pumps Market (By Product: Mechanical, Non-mechanical; By Application: Drug Delivery, Medical Devices; By End Use) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.

    Read more...
  • Featured Research Reports

    U.S. Behavioral Health Care Software And Services Market (By Component: Software, Support Services; By Delivery Model; By Function; By End Use) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.

    Read more...
  • Featured Research Reports

    Medical Imaging Market (By Product: X-ray, CT, MRI, Ultrasound; By End-use: Hospitals, Diagnostic Imaging Centers) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.

    Read more...
  • Featured Research Reports

    Medical Imaging Phantoms Market (By Device Type: X-ray, Ultrasound, CT, MRI; By End Use; By Material: Simulating Organs, False Organs) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.

    Read more...